Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 270
1.
Vet Res ; 52(1): 127, 2021 Oct 02.
Article En | MEDLINE | ID: mdl-34600565

Mammary pathogenic Escherichia coli (MPEC) is an important causative agent of mastitis in dairy cows that results in reduced milk quality and production, and is responsible for severe economic losses in the dairy industry worldwide. Oxidative stress, as an imbalance between reactive oxygen species (ROS) and antioxidants, is a stress factor that is common in most bacterial habitats. The presence of ROS can damage cellular sites, including iron-sulfur clusters, cysteine and methionine protein residues, and DNA, and may cause bacterial cell death. Previous studies have reported that Autoinducer 2 (AI-2) can regulate E. coli antibiotic resistance and pathogenicity by mediating the intracellular receptor protein LsrR. This study explored the regulatory mechanism of LsrR on the H2O2 stress response in MPEC, showing that the transcript levels of lsrR significantly decreased under H2O2 stress conditions. The survival cell count of lsrR mutant XW10/pSTV28 was increased about 3080-fold when compared with that of the wild-type WT/pSTV28 in the presence of H2O2 and overexpression of lsrR (XW10/pUClsrR) resulted in a decrease in bacterial survival rates under these conditions. The ß-galactosidase reporter assays showed that mutation of lsrR led to a remarkable increase in expression of the promoters of ahpCF, katG and oxyR, while lsrR-overexpressing significantly reduced the expression of ahpCF and katG. The electrophoretic mobility shift assays confirmed that LsrR could directly bind to the promoter regions of ahpCF and katG. These results revealed the important role played by LsrR in the oxidative stress response of MPEC.


Breast Diseases/veterinary , Cattle Diseases/physiopathology , Escherichia coli Proteins/genetics , Homoserine/analogs & derivatives , Hydrogen Peroxide/pharmacology , Lactones/metabolism , Quorum Sensing , Repressor Proteins/genetics , Animals , Base Sequence , Breast Diseases/microbiology , Breast Diseases/physiopathology , Cattle , Cattle Diseases/microbiology , DNA, Bacterial/analysis , Escherichia coli Proteins/metabolism , Female , Homoserine/metabolism , Mammary Glands, Animal/microbiology , Repressor Proteins/metabolism , Sequence Alignment/veterinary , Stress, Physiological
2.
Vet Res ; 52(1): 130, 2021 Oct 14.
Article En | MEDLINE | ID: mdl-34649594

Mycoplasma species are the smallest prokaryotes capable of self-replication. To investigate Mycoplasma induced autophagy in mammalian cells, Mycoplasma bovis (M. bovis) and bovine mammary epithelial cells (bMEC) were used in an in vitro infection model. Initially, intracellular M. bovis was enclosed within a membrane-like structure in bMEC, as viewed with transmission electron microscopy. In infected bMEC, increased LC3II was verified by Western blotting, RT-PCR and laser confocal microscopy, confirming autophagy at 1, 3 and 6 h post-infection (hpi), with a peak at 6 hpi. However, the M. bovis-induced autophagy flux was subsequently blocked. P62 degradation in infected bMEC was inhibited at 3, 6, 12 and 24 hpi, based on Western blotting and RT-PCR. Beclin1 expression decreased at 12 and 24 hpi. Furthermore, autophagosome maturation was subverted by M. bovis. Autophagosome acidification was inhibited by M. bovis infection, based on detection of mCherry-GFP-LC3 labeled autophagosomes; the decreases in protein levels of Lamp-2a indicate that the lysosomes were impaired by infection. In contrast, activation of autophagy (with rapamycin or HBSS) overcame the M. bovis-induced blockade in phagosome maturation by increasing delivery of M. bovis to the lysosome, with a concurrent decrease in intracellular M. bovis replication. In conclusion, although M. bovis infection induced autophagy in bMEC, the autophagy flux was subsequently impaired by inhibiting autophagosome maturation. Therefore, we conclude that M. bovis subverted autophagy to promote its intracellular replication in bMEC. These findings are the impetus for future studies to further characterize interactions between M. bovis and mammalian host cells.


Autophagy , Breast Diseases/veterinary , Cattle Diseases/physiopathology , Epithelial Cells/physiology , Mammary Glands, Animal/physiopathology , Mycoplasma bovis/physiology , Animals , Breast Diseases/microbiology , Breast Diseases/physiopathology , Cattle , Cattle Diseases/microbiology , Female , Mammary Glands, Animal/microbiology
3.
PLoS One ; 16(5): e0251182, 2021.
Article En | MEDLINE | ID: mdl-33983987

BACKGROUND: Lactation mastitis (LM) affects approximately 3% to 33% of postpartum women and the risk factors of LM have been extensively studied. However, some results in the literature reports are still not conclusive due to the complexity of LM etiology and variation in the populations. To provide nationally representative evidence of the well-accepted risk factors for LM in China, this study was aimed to systematically summary the risk factors for LM among Chinese women and to determine the effect size of individual risk factor. MATERIAL AND METHODS: Six major Chinses and English electronic literature databases (PubMed, Web of Science, Chinese Biomedical Literature Database, China National Knowledge Infrastructure, Wan fang Database and China Science Technology Journal Database) were searched from their inception to December 5st, 2020. Two authors extracted data and assessed the quality of included trials, independently. The strength of the association was summarized using the odds ratio (OR) with 95% confidence intervals (CI). The population attributable risk (PAR) percent was calculated for significant risk factors. RESULTS: Fourteen studies involving 8032 participants were included. A total of 18 potential risk factors were eventually evaluated. Significant risk factors for LM included improper milking method (OR 6.79, 95%CI 3.45-13.34; PAR 59.14%), repeated milk stasis (OR 6.23, 95%CI 4.17-9.30; PAR 49.75%), the first six months postpartum (OR 5.11, 95%CI 2.66-9.82; PAR 65.93%), postpartum rest time less than 3 months (OR 4.71, 95%CI 3.92-5.65; PAR 56.95%), abnormal nipple or crater nipple (OR 3.94, 95%CI 2.34-6.63; PAR 42.05%), breast trauma (OR 3.07, 95%CI 2.17-4.33; PAR 15.98%), improper breastfeeding posture (OR 2.47, 95%CI 2.09-2.92; PAR 26.52%), postpartum prone sleeping position (OR 2.46, 95%CI 1.58-3.84; PAR 17.42%), little or no nipple cleaning (OR 2.05, 95%CI 1.58-2.65; PAR 24.73%), primipara (OR 1.73, 95%CI 1.25-2.41; PAR 32.62%), low education level (OR 1.63, 95%CI 1.09-2.43; PAR 23.29%), cesarean section (OR 1.51, 95%CI 1.26-1.81; PAR 18.61%), breast massage experience of non-medical staff (OR 1.51, 95%CI 1.25-1.82; PAR 15.31%) and postpartum mood disorders (OR 1.47, 95%CI 1.06-2.02; PAR 21.27%). CONCLUSIONS: This review specified several important risk factors for LM in China. In particular, the incidence of LM can be reduced by controlling some of the modifiable risk factors such as improper breastfeeding posture, improper milking method, repeated milk stasis, nipple cleaning, breast massage experience of non-medical staff and postpartum sleeping posture.


Mastitis/epidemiology , Mastitis/etiology , Mastitis/prevention & control , Adult , Asian People/genetics , Breast Diseases/physiopathology , Breast Feeding/adverse effects , China/epidemiology , Female , Humans , Lactation/immunology , Lactation/metabolism , Lactation Disorders/physiopathology , Middle Aged , Nipples/physiology , Postpartum Period , Prone Position , Risk Factors , Sleep , Young Adult
4.
BMJ Case Rep ; 13(12)2020 Dec 12.
Article En | MEDLINE | ID: mdl-33310826

Tuberculosis (TB) of the breast is extremely rare and is often mistaken for benign or malignant lesions of the breast. They are rare even in countries which are endemic for TB, like India. The most common type of clinical presentation is a vague lump in the breast, but there are even other types of presentations which are documented. In olden days, there was a lot of dilemma and challenge in diagnosing TB of the breast, but thanks to improved pathological knowledge and the advent of investigations such as QuantiFERON-TB gold and GeneXpert, TB can be diagnosed early nowadays and treated accordingly. In this study series, we report 10 cases of TB of the breast with variable clinical presentations as fibroadenosis, breast abscess, duct ectasia and breast lump on evaluation, and the challenges encountered in establishing the diagnosis.


Breast Diseases/diagnosis , Breast/microbiology , Mycobacterium tuberculosis/isolation & purification , Tuberculosis/diagnosis , Adult , Breast/pathology , Breast Diseases/physiopathology , DNA, Bacterial/analysis , Diagnosis, Differential , Female , Humans , India , Middle Aged , Retrospective Studies
5.
Adv Exp Med Biol ; 1252: 33-39, 2020.
Article En | MEDLINE | ID: mdl-32816260

The breast tissue undergoes significant physiological change during pregnancy and lactation. These changes can give rise to some unique disorders during pregnancy , puerperium and lactation or exaggerate pre-existing conditions. Clinical examination becomes less reliable due to textural change and density of breast tissue as a result of hormonal changes. The main symptoms during pregnancy and lactation are breast pain, mastitis, lactational abscess, breast lump, and blood- stained nipple discharge.Lactational mastitis/ abscess must be treated without delay. Open incision and drainage of lactational abscess is rarely required, any lactational abscess should be treated with appropriate antibiotics and ultrasound guided aspiration of the pus.Any breast lump during pregnancy and lactation should be investigated with triple assessment. Pregnancy associated breast cancer (PABC ) must be ruled out. The choice of investigations and treatment needs careful consideration. While ultrasound is the investigation of choice, mammography can be performed with abdominal shielding if malignancy is suspected. Core biopsy is necessary for evaluation of any breast pathology but it comes with risk of infection, bleeding, hematoma and even milk fistula.The treating clinical specialist must be aware of certain unusual unique clinical conditions in pregnancy and lactation including accessory axillary breast tissue, gigantomastia and Raynaud's phenomenon.


Breast Diseases/diagnosis , Breast Diseases/physiopathology , Lactation , Pregnancy Complications , Abscess , Breast , Breast Diseases/pathology , Breast Feeding , Female , Humans , Mastitis , Pregnancy
6.
Eur J Surg Oncol ; 46(4 Pt B): 717-736, 2020 04.
Article En | MEDLINE | ID: mdl-32075718

The Breast Surgery theoretical and practical knowledge curriculum comprehensively describes the knowledge and skills expected of a fully trained breast surgeon practicing in the European Union and European Economic Area (EEA). It forms part of a range of factors that contribute to the delivery of high quality cancer care. It has been developed by a panel of experts from across Europe and has been validated by professional breast surgery societies in Europe. The curriculum maps closely to the syllabus of the Union of European Medical Specialists (UEMS) Breast Surgery Exam, the UK FRCS (breast specialist interest) curriculum and other professional standards across Europe and globally (USA Society of Surgical Oncology, SSO). It is envisioned that this will serve as the basis for breast surgery training, examination and accreditation across Europe to harmonise and raise standards as breast surgery develops as a separate discipline from its parent specialties (general surgery, gynaecology, surgical oncology and plastic surgery). The curriculum is not static but will be revised and updated by the curriculum development group of the European Breast Surgical Oncology Certification group (BRESO) every 2 years.


Breast Diseases/diagnosis , Breast Diseases/therapy , Curriculum/standards , Surgical Oncology/education , Surgical Oncology/standards , Breast/anatomy & histology , Breast/physiology , Breast/surgery , Breast Diseases/physiopathology , Certification/methods , Certification/standards , Clinical Competence/standards , Education, Medical/standards , Europe , Fellowships and Scholarships/standards , Humans , Internship and Residency/standards
7.
Plast Reconstr Surg ; 145(3): 632-642, 2020 03.
Article En | MEDLINE | ID: mdl-32097297

BACKGROUND: Animation deformity is an undesirable outcome of subpectoral breast reconstruction that results in abnormal breast contraction with activity, breast pain, and increased implant visibility. Surgical correction requires implant removal and conversion of the reconstruction to a prepectoral plane. The authors present their institutional experience with their preferred surgical technique to treat this challenging problem and outline solutions for increased success in these patients. METHODS: A retrospective review was performed of all patients undergoing conversion of their subpectoral breast reconstruction to a prepectoral plane at the authors' institution. Patient demographics and surgical details were analyzed, and postoperative outcomes and morbidity were assessed. The effects of changing operative strategies on enhanced success are also reported. RESULTS: A total of 80 breast conversions were performed over a 2.5-year period. All patients demonstrated resolution of animation deformity at a mean follow-up of 15.2 months. Two reconstructions (2.5 percent) required an unplanned return to the operating room, and 11 reconstructions (13.8 percent) were treated for infection. Preconversion fat grafting and the use of acellular dermal matrix were both associated with a reduced incidence of postoperative asymmetry and capsular contracture (p < 0.05). There were no reconstructive failures associated with conversion to a prepectoral pocket. CONCLUSIONS: Treatment of animation deformity in the reconstructed patient can be safely performed by surgical conversion to a prepectoral plane. The use of acellular dermal matrix, and preconversion fat grafting, in appropriate patients can improve results. The authors promote this operative algorithm for all reconstructive patients experiencing symptomatic animation deformity with subpectoral breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.


Breast Diseases/surgery , Breast Implantation/adverse effects , Pectoralis Muscles/transplantation , Postoperative Complications/surgery , Reoperation/methods , Adult , Breast/physiopathology , Breast/surgery , Breast Diseases/etiology , Breast Diseases/physiopathology , Breast Implantation/instrumentation , Breast Implantation/methods , Breast Implants/adverse effects , Device Removal , Female , Follow-Up Studies , Humans , Middle Aged , Movement , Postoperative Complications/etiology , Postoperative Complications/physiopathology , Retrospective Studies
8.
Breast J ; 26(2): 235-239, 2020 02.
Article En | MEDLINE | ID: mdl-31486176

SETTING: Breast tuberculosis (TB) is rare in Western Europe, and its diagnosis may be delayed through lack of awareness of presenting features. Our institution serves a large East London population with a high incidence of TB. OBJECTIVE: To characterize presenting features and avoidable diagnostic delay in breast TB patients. DESIGN: We conducted a 13-year retrospective study of breast TB patients treated at our institution including demographic, clinical, microbiology, and pathology data. RESULTS: Forty-seven cases were included; 44 (94%) were female, with a median age of 33 years (IQR 28.5-39.5). The main presenting feature was a breast lump in 41 cases (87%); which were predominantly solitary unilateral lesions (25, 61%) and frequently located in the upper outer quadrant (28, 68%). Where performed, Mycobacterium tuberculosis was cultured in 15/36 (42%) cases. Granulomata were present on biopsy or aspirate in 21 (47%) and 17 (36%) cases, respectively. The median duration between symptom onset and treatment was 20 weeks (IQR 15-30). Forty-six (98%) completed treatment successfully and one relapsed. CONCLUSION: A high index of suspicion for TB is required for individuals presenting with breast symptoms from countries where TB is endemic. Development of standardized pathways may improve detection and management of breast TB may reduce diagnostic delay.


Breast Diseases/diagnosis , Tuberculosis/diagnosis , Adult , Antitubercular Agents/therapeutic use , Axilla , Breast Diseases/drug therapy , Breast Diseases/pathology , Breast Diseases/physiopathology , Culture Techniques , Duration of Therapy , Erythema/physiopathology , Female , Humans , Lactation , London , Lymphadenopathy/physiopathology , Male , Mammography , Mastodynia/physiopathology , Nipple Discharge , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/pathology , Pregnancy Complications, Infectious/physiopathology , Retrospective Studies , Tuberculosis/drug therapy , Tuberculosis/pathology , Tuberculosis/physiopathology , Ultrasonography, Mammary
9.
Eur J Med Genet ; 63(1): 103615, 2020 Jan.
Article En | MEDLINE | ID: mdl-30654152

Ulnar-mammary syndrome (UMS) is a rare syndromic limb malformation caused by heterozygous mutations in TBX3. The name highlights the two commonly involved body parts i.e. mammary gland and ulnar ray of the upper limbs, although a more extensive systemic involvement is also known to occur. Here, we report the surprising finding of a patient with a de novo mutation in TBX3 whose clinical presentation is limited to dorsalization of both little fingers and slightly deep 4th web spaces. We review the literature to confirm that this should be considered as a forme fruste phenotype of UMS.


Abnormalities, Multiple/genetics , Breast Diseases/genetics , Limb Deformities, Congenital/genetics , T-Box Domain Proteins/genetics , Ulna/abnormalities , Abnormalities, Multiple/physiopathology , Breast Diseases/physiopathology , Child , Female , Fingers/abnormalities , Fingers/physiopathology , Humans , Limb Deformities, Congenital/physiopathology , Mutation/genetics , Phenotype , Ulna/physiopathology
10.
Trials ; 20(1): 737, 2019 Dec 16.
Article En | MEDLINE | ID: mdl-31842992

BACKGROUND: Breastfeeding provides ideal infant nutrition, conferring several health benefits to children and their mothers. Women with inverted nipples, however, face difficulties that force them to prematurely terminate breastfeeding. Whereas available conservative measures for the correction of inverted nipples are of limited success, the use of an inverted syringe may be effective in achieving high rates of infant latching and exclusive breastfeeding. This technique, however, has not been investigated in a clinical trial. METHODS/DESIGN: This open-label randomized controlled trial aims to investigate whether, in women with inverted nipples, the use of an inverted syringe increases the rate of exclusive breastfeeding at one month compared to standard care. One-hundred healthy women with grade 1 or 2 inverted nipples will be recruited as of 37 weeks of gestation. They will be randomly allocated to standard care (control group) or to an intervention group. The intervention consists of using an inverted syringe to evert the nipple before every breastfeed, starting with the first feed after delivery. The primary outcome measure is the rate of exclusive breastfeeding at 1 month. Secondary outcome measures include exclusive breastfeeding rates at 3 and 6 months, nipple eversion rate, successful latching rate, rates of any breastfeeding at 1, 3, and 6 months, breastfeeding-associated complications, maternal satisfaction with breastfeeding, maternal quality of life, and adverse events. Descriptive and regression analysis will be conducted under the intention to treat basis. DISCUSSION: The use of the inverted syringe to evert inverted nipples is a simple, inexpensive, and safe technique that can be performed by mothers with inverted nipples. Findings of this trial, if positive, will provide much needed evidence for a safe, affordable, readily available, and simple intervention to treat inverted nipples, and improve breastfeeding practice among affected women. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03529630. Registered May 8, 2018.


Breast Diseases/therapy , Breast Feeding/instrumentation , Lactation , Nipples/physiopathology , Syringes , Breast Diseases/diagnosis , Breast Diseases/physiopathology , Female , Humans , Infant , Infant, Newborn , Lebanon , Nipples/abnormalities , Randomized Controlled Trials as Topic , Time Factors , Treatment Outcome
11.
Curr Opin Obstet Gynecol ; 31(5): 293-297, 2019 10.
Article En | MEDLINE | ID: mdl-31356237

PURPOSE OF REVIEW: This article will provide an overview on female breast development and focus on common abnormalities of growth, the emerging role of breast self-awareness, and discuss trends in the evaluation and treatment of the breast masses and disorders most often encountered in the female adolescent population. RECENT FINDINGS: Although the embryology of breast development is unchanged, data are emerging on the role of environmental factors on the timing of puberty and thelarche. As breast development occurs, the role of breast self-awareness is also a new trend that allows teens to be cognizant of changes in their own breast and to become more comfortable with their own anatomy. Finally, when breast treatments are needed or desired, the timing of breast treatments is a subject that must be individualized. SUMMARY: There are numerous conditions that can result from disruption of normal breast development. These resultant breast disorders are generally benign but can still cause emotional distress to both the patient and family. It is thus imperative that healthcare providers be educated on breast development, the common breast masses that occur in the adolescent population and be prepared to discuss breast self-awareness and shared decision-making in this population.


Breast Diseases/physiopathology , Breast/growth & development , Adolescent , Breast/embryology , Breast Diseases/diagnosis , Breast Diseases/therapy , Female , Humans , Menarche/physiology
12.
Breast J ; 25(5): 977-979, 2019 09.
Article En | MEDLINE | ID: mdl-31165552

Mammary duct ectasia (MDE) is a benign and often troublesome breast condition. The usual presentation includes colored nipple discharge and mastalgia. Nipple hypersensitivity has never before been described as a presenting complaint for MDE. This case report looks into such an unusual case.


Breast Diseases/physiopathology , Breast Diseases/surgery , Nipples/physiopathology , Dilatation, Pathologic/pathology , Female , Humans , Mammary Glands, Human/pathology , Mammary Glands, Human/surgery , Middle Aged
13.
J Adv Nurs ; 75(11): 2638-2646, 2019 Nov.
Article En | MEDLINE | ID: mdl-31016759

AIMS: To identify unobserved body composition patterns among Chinese women with breast diseases using latent class analysis (LCA) and to examine the relationship between body composition patterns and breast cancer (BC) risk. DESIGN: A descriptive, cross-sectional study. METHODS: Female patients (N = 1816) with breast diseases were included in the study from April 2016 - March 2017. Body composition measures were done by the bioelectrical impedance analysis. The LCA models were estimated using Mplus 8.1. RESULTS: Four latent classes were identified based on water, protein, minerals and body fat mass: Class 1 - Low Muscle Mass class; Class 2 - High Body Composition class; Class 3 - High Fat class; and Class 4 - Normal Body Composition Class. Classes 2 and 3 are higher risk classes for developing BC compared with the other two classes (p < 0.05). Overall, age is positively associated with the odds of BC development (p < 0.001). However, age effect depends on the body composition patterns. Age effect on the odds of BC was statistically significant only for women who had least body fat mass (Class 1, OR = 1.110, 95% C.I.: 1.084-1.136) or had normal body composition (Class 4, OR = 1.090, 95% C.I.: 1.036-1.147). The effect of age was not statistically significant if women had higher risk body composition (e.g., in Classes 2 or 3). CONCLUSION: Latent Class Analysis is a useful person-centred analytical approach for identification of unobserved patterns of body composition and it could be used to predict the risk of BC and develop personalized interventions for body composition studies.


Body Composition , Breast Diseases/physiopathology , Breast Neoplasms/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Breast Neoplasms/physiopathology , China/epidemiology , Cross-Sectional Studies , Female , Humans , Middle Aged , Reproducibility of Results , Risk Factors , Young Adult
14.
Medicine (Baltimore) ; 98(15): e15125, 2019 Apr.
Article En | MEDLINE | ID: mdl-30985674

To evaluate the diagnostic performance of percentage of hard component (PHC) versus strain ratio (SR) in focal breast lesion diagnosis.Ultrasonography and elastography images of 245 malignant and 255 benign breast lesions were obtained and analyzed according to the Breast Imaging-Reporting and Data System of the American College of Radiology. PHC and SR were measured for each lesion and receiver operating characteristic (ROC) curve analysis was performed to evaluate and compare the diagnostic performance of conventional ultrasound (CU) only, PHC with CU, and SR with CU.Mean PHC differed significantly between malignant (90.46 ±â€Š13.29) and benign (62.03 ±â€Š25.61) lesions. Mean SR differed significantly between malignant (4.61 ±â€Š1.75) and benign (2.34 ±â€Š1.80) lesions. ROC curve threshold values were 82.45 for PHC and 2.69 for SR. The area under the curve values for CU, SR with CU, and PHC with CU were 0.956, 0.960, and 0.956, respectively, with no significant differences among them (P < .05).PHC was comparable to SR for differentiating malignant from benign breast masses and may be an auxiliary tool for breast lesion stiffness evaluation. ROC data for CU, SR with CU, and PHC with CU were statistically similar.


Breast Diseases/diagnostic imaging , Ultrasonography , Adolescent , Adult , Aged , Aged, 80 and over , Biomechanical Phenomena , Breast/diagnostic imaging , Breast Diseases/physiopathology , Diagnosis, Differential , Elasticity , Female , Humans , Middle Aged , ROC Curve , Ultrasonography/methods , Young Adult
15.
PLoS One ; 14(1): e0210973, 2019.
Article En | MEDLINE | ID: mdl-30653590

BACKGROUND: Breast arterial calcification (BAC) may be a predictor of cardiovascular events and is highly prevalent in persons with end-stage kidney disease. However, few studies to date have examined the association between mild-to-moderate kidney function and proteinuria with BAC. METHODS: We prospectively enrolled women with no prior cardiovascular disease aged 60 to 79 years undergoing mammography screening at Kaiser Permanente Northern California between 10/24/2012 and 2/13/2015. Urine albumin-to-creatinine ratio (uACR), along with specific laboratory, demographic, and medical data, were measured at the baseline visit. Baseline estimated glomerular filtration rate (eGFR), medication history, and other comorbidities were identified from self-report and/or electronic medical records. BAC presence and gradation (mass) was measured by digital quantification of full-field mammograms. RESULTS: Among 3,507 participants, 24.5% were aged ≥70 years, 63.5% were white, 7.5% had eGFR <60 ml/min/1.73m2, with 85.7% having uACR ≥30 mg/g and 3.3% having uACR ≥300 mg/g. The prevalence of any measured BAC (>0 mg) was 27.9%. Neither uACR ≥30 mg/g nor uACR ≥300 were significantly associated with BAC in crude or multivariable analyses. Reduced eGFR was associated with BAC in univariate analyses (odds ratio 1.53, 95% CI: 1.18-2.00), but the association was no longer significant after adjustment for potential confounders. Results were similar in various sensitivity analyses that used different BAC thresholds or analytic approaches. CONCLUSIONS: Among women without cardiovascular disease undergoing mammography screening, reduced eGFR and albuminuria were not significantly associated with BAC.


Breast Diseases/diagnostic imaging , Breast Diseases/physiopathology , Vascular Calcification/diagnostic imaging , Vascular Calcification/physiopathology , Aged , Breast/blood supply , Breast/diagnostic imaging , Breast Diseases/epidemiology , California/epidemiology , Cardiovascular Diseases/epidemiology , Cohort Studies , Comorbidity , Female , Glomerular Filtration Rate , Humans , Kidney Function Tests , Mammography , Middle Aged , Multivariate Analysis , Prevalence , Prospective Studies , Proteinuria/epidemiology , Proteinuria/physiopathology , Renal Insufficiency, Chronic/epidemiology , Renal Insufficiency, Chronic/physiopathology , Vascular Calcification/epidemiology
16.
J Invest Surg ; 32(7): 624-631, 2019 Nov.
Article En | MEDLINE | ID: mdl-29537901

Purpose of the study: Hypofunctioning breasts are typically considered a dysfunction of higher brain centers that regulate hormonal feedback, and olfactory information has been proposed as a triggering factor for lactation in the maternal body. However, there are no substantive studies regarding whether olfaction disorders and/or loss of olfactory sense may result in breast gland atrophy by causing diminished olfactory stimulation. To fill this gap in the literature, we studied the histologic features of breast glands as a sample model in animals that had undergone an olfactory bulb lesion (OBL). Materials and methods: This study was conducted on 22 rats. Six, eight, and six of them were used as control, SHAM, and OBL groups, respectively. After 10 weeks, the animals were decapitated. Olfactory bulbs and breast glands were stained with Hematoxylin-eosin and tunnel dye. Specimens were analyzed stereologically to evaluate the loss in volume of the olfactory bulbs, total breast follicle volume (TBFV) and Meissner's corpuscles per cubic centimeter, and these two senior metrics were compared with each other statistically. Results: Olfactory bulb volume loss and breast gland atrophy were both detected in study group. Mean TBFV and OB volumes were measured as: (296 ± 89) × 106 µm3/cm3 and 4.43 ± 0.98 mm3 in control (Group I); (264 ± 63) × 106 µm3/cm3 and 3.86 ± 0.81 mm3 in SHAM (Group II) and (194 ± 52) × 106 µm3/cm3 and 1.52 ± 0.36 mm3 in OBL group (Group III). It was noted that the TBFV was significantly diminished, with apoptotic degradation in the olfactory bulbs and breast glands of OBL-applied animals (p < 0.001). Conclusion: It seems that diminished milk secretion is attributable to the degradation of breast glands that results from olfaction loss in OBL animals.


Breast Diseases/etiology , Mammary Glands, Animal/pathology , Nerve Net/injuries , Olfaction Disorders/complications , Olfactory Bulb/injuries , Animals , Atrophy/etiology , Atrophy/pathology , Atrophy/physiopathology , Breast Diseases/pathology , Breast Diseases/physiopathology , Disease Models, Animal , Female , Lactation/physiology , Mammary Glands, Animal/physiopathology , Olfaction Disorders/etiology , Rats
17.
Biochim Biophys Acta Rev Cancer ; 1869(2): 310-320, 2018 Apr.
Article En | MEDLINE | ID: mdl-29684522

The implementation of mammographic screening programmes in many countries has been linked to a marked increase in early detection and improved prognosis for breast cancer patients. Breast tumours can be detected by assessing several features in mammographic images but one of the most common are the presence of small deposits of calcium known as microcalcifications, which in many cases may be the only detectable sign of a breast tumour. In addition to their efficacy in the detection of breast cancer, the presence of microcalcifications within a breast tumour may also convey useful prognostic information. Breast tumours with associated calcifications display an increased rate of HER2 overexpression as well as decreased survival, increased risk of recurrence, high tumour grade and increased likelihood of spread to the lymph nodes. Clearly, the presence of microcalcifications in a tumour is a clinically significant finding, suggesting that a detailed understanding of their formation may improve our knowledge of the early stages of breast tumourigenesis, yet there are no reports which attempt to bring together recent basic science research findings and current knowledge of the clinical significance of microcalcifications. This review will summarise the most current understanding of the formation of calcifications within breast tissue and explore their associated clinical features and prognostic value.


Breast Diseases/diagnostic imaging , Breast Neoplasms/diagnostic imaging , Calcinosis/diagnostic imaging , Cell Transformation, Neoplastic , Early Detection of Cancer/methods , Mammography , Animals , Breast Diseases/pathology , Breast Diseases/physiopathology , Breast Neoplasms/pathology , Breast Neoplasms/physiopathology , Calcinosis/pathology , Calcinosis/physiopathology , Cell Transformation, Neoplastic/pathology , Female , Humans , Predictive Value of Tests , Prognosis , Risk Factors , Tumor Microenvironment
18.
J Med Case Rep ; 12(1): 4, 2018 Jan 09.
Article En | MEDLINE | ID: mdl-29310702

BACKGROUND: Chest pain is one of the common presenting symptoms encountered in an emergency department. Prompt history taking and careful clinical examination do help to differentiate cardiac chest pain from other causes. Mondor's disease is a rare cause of chest pain which is often underdiagnosed due to lack of awareness. Mondor's disease is a condition characterized by thrombophlebitis of the superficial veins of breast and anterior chest wall. The diagnosis is often made clinically. CASE PRESENTATION: Here we report a case of a 37-year-old Sri Lankan Tamil woman who presented with chest pain and was clinically diagnosed as having Mondor's disease after a physical examination, which was confirmed with demonstration of thrombophlebitis by ultrasound scan imaging. Although it is a self-limiting condition, non-steroidal anti-inflammatory drugs are used in the treatment to hasten recovery in addition to giving reassurance. CONCLUSIONS: Mondor's disease is not considered a differential diagnosis for chest pain due to lack of awareness of this medical condition. Creating awareness of this condition via this case would help to cut down unnecessary investigations and valuable time spent in emergency departments, and it helps to identify a serious underlying cause especially carcinoma of the breast at its early stage.


Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Breast/blood supply , Chest Pain , Thrombophlebitis , Veins , Adult , Breast Diseases/complications , Breast Diseases/diagnosis , Breast Diseases/physiopathology , Chest Pain/diagnosis , Chest Pain/etiology , Diagnosis, Differential , Female , Humans , Physical Examination/methods , Thrombophlebitis/complications , Thrombophlebitis/diagnosis , Thrombophlebitis/drug therapy , Thrombophlebitis/physiopathology , Treatment Outcome , Ultrasonography/methods , Veins/diagnostic imaging , Veins/pathology
19.
Article En | MEDLINE | ID: mdl-28935365

Breast development in the female is a process that becomes noticeable during puberty, and defines a girl's transition into adulthood. Various conditions can disrupt or alter the normal development, which may lead to abnormal breast changes and features. Further, the finding of a breast mass in adolescence can be unsettling to the patient and her family. While the majority of these breast changes and/or masses tend to be benign and self-limited, the appropriate evaluation is always warranted. This chapter will focus on the normal and abnormal development of breasts. We will also discuss the evaluation and management of breast masses that can be found in the adolescent female.


Breast Diseases/physiopathology , Breast/growth & development , Adolescent , Female , Humans , Puberty/physiology
...